Arcadia Biosciences, Inc. (NASDAQ:RKDA – Get Free Report)’s share price passed above its 50-day moving average during trading on Tuesday . The stock has a 50-day moving average of $3.78 and traded as high as $3.80. Arcadia Biosciences shares last traded at $3.71, with a volume of 17,323 shares trading hands.
Analyst Ratings Changes
Separately, Weiss Ratings reiterated a “sell (d-)” rating on shares of Arcadia Biosciences in a research note on Monday. One equities research analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the company currently has a consensus rating of “Sell”.
View Our Latest Stock Analysis on RKDA
Arcadia Biosciences Stock Down 0.5%
Arcadia Biosciences (NASDAQ:RKDA – Get Free Report) last posted its quarterly earnings results on Friday, November 7th. The basic materials company reported $0.62 earnings per share for the quarter, topping analysts’ consensus estimates of ($0.54) by $1.16. The firm had revenue of $1.30 million for the quarter, compared to analyst estimates of $1.90 million. Arcadia Biosciences had a negative net margin of 139.36% and a negative return on equity of 34.75%.
Arcadia Biosciences Company Profile
Arcadia Biosciences, Inc produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring.
See Also
- Five stocks we like better than Arcadia Biosciences
- Utilities Stocks Explained – How and Why to Invest in Utilities
- What’s on the Thanksgiving Table? A Stock Pick for Every Course
- How to Use High Beta Stocks to Maximize Your Investing Profits
- Why Home Depot’s Pain Could Be a Long-Term Investor’s Gain
- How to Invest in the Best Canadian Stocks
- Qualcomm’s Bulls Are Running Out of Room to Be Wrong
Receive News & Ratings for Arcadia Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arcadia Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.
